TrialStem cell research & therapy2022

Safety and efficacy study of allogeneic human menstrual blood stromal cells secretome to treat severe COVID-19 patients: clinical trial phase I & II.

Mina Fathi-Kazerooni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.